Global Medical Director, Riliprubart

Role Summary

Global Medical Director for riliprubart, responsible for leading the medical strategy across the product value chain, coordinating evidence generation, and driving medical programs to demonstrate therapeutic value. Partners with Medical Evidence Generation, CSU, RWE, HEVA, MO&E, and country teams to advance scientific knowledge and clinical care. Oversees medical affairs studies, medical communications, and stakeholder engagement to evolve the treatment landscape for CIDP and riliprubart.

Responsibilities

• Co-develop, plan and lead the execution of the medical strategy for riliprubart across the product value chain.
• Co-create the IEGP strategy with Medical Evidence Generation Lead and other evidence generation-related functions: CSU, RWE, HEVA, MO&E and country teams.
• Lead the execution of assigned medical affairs studies. Provide input in design, monitoring, analysis, and communication of the assigned studies. Serve as a global medical point of contact for such studies for internal and external stakeholders.
• Oversee insight generation plan and input to the assigned asset's overall medical strategy.
• Provide strategic input to Scientific Communications team to plan and execute evidence dissemination and medical education plans.
• Build trust with global external stakeholders to advance their understanding of the therapeutic area and evolve the treatment landscapes for CIDP and riliprubart.
• Oversee the design of medical programs/initiatives to drive the therapeutic value of riliprubart and address unmet medical needs (i.e., MAPs, PSP, Diagnostic support programs, CSRs, etc).
• Oversee adherence to allocated budgets, plan and execute activities aligned with strategy and smart execution principles to assure prioritization and cross-functional alignment.
• Accountable for medical affairs review and scientific integrity of internal and external medical materials.

Qualifications

• Deep expertise in Neurology & Neuromuscular Diseases, preferred.
• Minimum of 4 years’ experience in relevant Medical Affairs.
• Demonstrated industry experience in strategic medical affairs or clinical development roles including scientific KOL engagement, evidence generation and scientific communication at Global and Key Market level, preferred.
• Broad drug development experience with knowledge of regulatory, market access and reimbursement.
• Experience managing clinical trials in a pharmaceutical environment is strongly desired.
• Specialty care product launch experience at a country level, strongly preferred.
• Significant line and matrix management experience, with collaboration across Research, Clinical Development, Commercial, Health Economics, Value and Access, and Product Management functions.

Skills

• Strategic thinking: disrupt status quo with innovation while remaining pragmatic and focused on priorities.
• Result orientation: develop and execute strategies that meet objectives, with pragmatic solutions and adaptability.
• People Leadership: engage teams, provide coaching and support, set high standards, and facilitate collaboration.
• Relationships and Influence: effective stakeholder management and collaboration.
• Highest ethical, regulatory and scientific standards.
• Languages: Fluent in English.

Education

• Doctorate in a relevant scientific discipline or Pharmacy – Medical Degree preferred.
• Languages: Fluent in English.